On May 31, Bloomberg reported that the FDA recently granted Moderna Inc. (NASDAQ:MRNA) a narrower approval for its next-generation COVID-19 vaccine.
Keep Reading →
June 2 - News
We recently published a list of Jim Cramer Talked About These 13 Stocks. In this article, we are going to take a look at where Moderna, Inc.
Keep Reading →
May 26 - News
“If you want to know what makes a successful retailer, all you have to do is read the conference calls. Everything's on display, no secret sauces.
Keep Reading →
May 26 - Hedge Funds, News
Moderna, Inc. (NASDAQ:MRNA) announced on Friday that it has submitted a marketing application to the U.S.
Keep Reading →
May 23 - News
We recently published a list of 10 Firms Drenched in Red Today.
Keep Reading →
May 21 - News
We recently published a list of These 10 Firms Just Beat the Market Today.
Keep Reading →
May 20 - News
Moderna, Inc. (NASDAQ:MRNA) shares soared to the top of the S&P 500 gainers in early afternoon trading on May 20, surging by 11%. The rise followed the U.S.
Keep Reading →
May 20 - News
We recently published a list of 10 Stocks That Stole the Show Today.
Keep Reading →
May 19 - News
He emphasized that natural gas is heavily influenced by federal policy, especially when it comes to exports.
Keep Reading →
May 16 - Hedge Funds, News
Back in 2024, on May 14, Mad Money’s Jim Cramer was asked about Moderna, Inc.
Keep Reading →
May 16 - News
The market closed last week mostly lower, however, the S&P 500 has been up more than 7% since April 11, indicating a returning positive sentiment.
Keep Reading →
May 13 - Hedge Funds, News
David E. Shaw is one billionaire investor whose record speaks for itself on Wall Street. Having founded D.E. Shaw & Co., L.P.
Keep Reading →
May 10 - Hedge Funds, News
Operator: Good day, and thank you for standing by. Welcome to the Moderna First Quarter 2025 Conference Call. At this time, all participants are in a listen-only mode.
Keep Reading →
May 2 - News, Transcripts
After a two-year surge of 53%, marking the best performance for the broad market index since the 1997-98 rally, stocks have been taken for a wild ride in 2025 due to uncertainties...
Keep Reading →
April 30 - Hedge Funds, News
As per Barclays, the US administration announced numerous executive orders with reforms associated with world trade, immigration, and global geopolitics, resulting in elevated...
Keep Reading →
April 8 - Hedge Funds, News
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer commented on the increasing bearishness in the stock market.
Keep Reading →
April 4 - News
Gene editing is an advanced medical technique within gene therapy that involves precisely modifying an individual’s DNA to treat or prevent diseases.
Keep Reading →
March 31 - Hedge Funds, News
“It's time to praise the winners, the ones that don't need to wait until April 2nd to find out whether their business will be slammed by tariffs when President Trump announces...
Keep Reading →
March 27 - Hedge Funds, News
During the most recent episode of Mad Money, Jim Cramer described the current stock market as a “short sellers paradise,” offering an ideal moment for those betting against...
Keep Reading →
March 25 - Hedge Funds, News
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.
Keep Reading →
March 24 - Hedge Funds, News
The Federal Reserve this week decided to keep interest rates unchanged, causing Donald Trump to lash out at the Fed chief.
Keep Reading →
March 23 - News, Stock Analysis
The recent pullback in US equities can be a sign of an aging bull market and a reaction to developments happening around trade policy, as per Jurrien Timmer, Director of Global...
Keep Reading →
March 20 - Hedge Funds, News
A German court ruled that BioNTech (BNTX) and Pfizer (PFE) have to pay Moderna damages because they infringed on Moderna's mRNA patents.
Keep Reading →
March 5 - Market Movers, News
We came across a bullish thesis on Moderna, Inc. (MRNA) on wallstreetbets Subreddit Page by YouAlwaysHaveAChoice.
Keep Reading →
February 26 - News, Stock Analysis
On February 24, CNBC reported that President Trump declared that sweeping US tariffs on imports from Mexico and Canada “will go forward” in a statement before the expiry of...
Keep Reading →
February 25 - Hedge Funds, Industries, News
Moderna, Inc. (NASDAQ:MRNA) Q4 2024 Earnings Call Transcript February 14, 2025Moderna, Inc. misses on earnings expectations.
Keep Reading →
February 17 - News, Transcripts
McKinsey reported that, since 2019, the US healthcare industry witnessed significant financial pressure.
Keep Reading →
February 7 - Hedge Funds, Industries, News
2024 was a memorable year for the broad market index, which posted a gain of 23.31%, building on the 24.2% return in 2023.
Keep Reading →
February 1 - Hedge Funds, News
The latest guidance reduction was the second time in the last six months that the firm has revised its forecast in a negative direction, according to Goldman analyst Salveen Richter...
Keep Reading →
January 29 - Market Movers, News
mRNA vaccine developer Moderna (MRNA) is climbing nearly 5% in early trading today after it was awarded about $590 million by the U.S.
Keep Reading →
January 21 - Market Movers, News
Jim Cramer's appearance on Squawk on the Street aired on January 17th covered a wide variety of topics.
Keep Reading →
January 19 - News
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer commented on the devastation ushered in by the California wildfire calamity, social media CEO Mark Zuckerberg...
Keep Reading →
January 18 - News
The earnings season is upon us and the investors are excited to see how the market sets the pace for the rest of 2025.
Keep Reading →
January 15 - Hedge Funds, News
Jim Cramer, host of Mad Money, recently discussed the current state of the market and also discussed both the leading and lagging stocks within the S&P 500.
Keep Reading →
January 10 - Hedge Funds, News
Shares of Sibanye Stillwater grew by 4.78 percent on Tuesday, adding $0.16 to close at $3.51 each as investor sentiment was boosted by news citing aides of incoming president ...
Keep Reading →
January 7 - Market Movers, News
The Louisiana Department of Health noted yesterday that a 65-year-old hospital patient had died due to bird flu.
Keep Reading →
January 7 - Market Movers, News
The Dow Jones Industrial Average dipped by 0.07 percent, the S&P 500 shed 0.43 percent, and the Nasdaq Composite declined by 0.90 percent.
Keep Reading →
January 1 - Market Movers, News
In his latest appearance on CNBC's Squawk on the Street, Jim Cramer continued to talk about the incoming Trump administration's tariffs.
Keep Reading →
December 18 - Market Movers, News
With 2024 coming to a close, investors have left several unknown variables behind them.
Keep Reading →
December 16 - News
During lean economic times, investing in healthcare stocks is generally regarded as defensive.
Keep Reading →
November 30 - Hedge Funds, News
We came across a bullish thesis on Moderna, Inc. (MRNA) on Substack by Natan. In this article, we will summarize the bulls’ thesis on MRNA. Moderna, Inc.
Keep Reading →
November 30 - News, Stock Analysis
The healthcare industry remains a vital and resilient sector which is driven by advancements in technology, increasing global demand, and an aging population.
Keep Reading →
November 26 - Hedge Funds, News
Investing in healthcare stocks during lean economic times is generally regarded as defensive.
Keep Reading →
November 25 - Hedge Funds, News
According to the World Health Organization (WHO), cancer remains one of the leading causes of death globally, responsible for nearly 10 million deaths in 2020, or about one in...
Keep Reading →
November 22 - Hedge Funds, Industries, News
Biotechnology stocks are among the most volatile in the market due to their high risk.
Keep Reading →
November 21 - Hedge Funds, News
With the 2024 US Presidential Election having come to a close, Wall Street can now focus on the future of artificial intelligence, the Federal Reserve's interest rate cut cycle...
Keep Reading →
November 20 - News
BlackRock highlighted that its portfolio managers are broadly optimistic about US equities.
Keep Reading →
November 14 - Hedge Funds, News
Operator: Good day and thank you for standing by. Welcome to the Moderna third quarter 2024 conference call. At this time, all participants are in a listen-only mode.
Keep Reading →
November 9 - News, Transcripts